Is HOOKIPA Pharma Inc halal to invest in?

According to Musaffa's Shariah screening methodology, HOOKIPA Pharma Inc (HOOK) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is HOOKIPA Pharma Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes HOOKIPA Pharma Inc using these criteria to determine its compliance status.

Can Muslims buy shares of HOOKIPA Pharma Inc?

Muslim investors may consider investing in HOOKIPA Pharma Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is HOOKIPA Pharma Inc classified as NOT HALAL?

Musaffa determines the Shariah status of HOOKIPA Pharma Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for HOOKIPA Pharma Inc updated?

The Shariah compliance status of HOOKIPA Pharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like HOOKIPA Pharma Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of HOOKIPA Pharma Inc?

You can check the latest Shariah compliance status of HOOKIPA Pharma Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

HOOK Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 12, 2025

Report Source: 2025 1st Quarter Report

Analyst's Ratings for HOOKIPA Pharma Inc (HOOK)

Based on 6 analysts giving stock ratings to HOOKIPA Pharma Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

HOOKIPA Pharma Inc. Stock Analysis HOOK

United States Health Care Nano Cap Report: Q1, 2025

HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The company is headquartered in New York City, New York and currently employs 82 full-time employees. The company went IPO on 2019-04-18. The firm's replicating and non-replicating technologies are engineered to induce robust and durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. The firm is also engaged in the assessment of strategic alternatives and the development of infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and its Human Immunodeficiency Virus (HIV) program, HB-500, are developed in a partnership with Gilead Sciences Inc.

Key Statistics of HOOKIPA Pharma Inc (HOOK)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.84$0.92

Today's Open

$0.90

Volume

1376.00

P/E Ratio (TTM)

52 Week Range

$0.81$1.77

Market Cap

14.67M

Avg. Volume

78.75K

Dividend Yield

Financial Metrics & Statements of HOOKIPA Pharma Inc (HOOK)

FAQ's for HOOKIPA Pharma Inc (HOOK)

According to Musaffa’s Shariah screening methodology, HOOKIPA Pharma Inc (HOOK) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.